These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17662314)

  • 21. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
    Brefel-Courbon C; Payoux P; Thalamas C; Ory F; Quelven I; Chollet F; Montastruc JL; Rascol O
    Mov Disord; 2005 Dec; 20(12):1557-63. PubMed ID: 16078219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Visual object recognition and attention in Parkinson's disease patients with visual hallucinations.
    Meppelink AM; Koerts J; Borg M; Leenders KL; van Laar T
    Mov Disord; 2008 Oct; 23(13):1906-12. PubMed ID: 18709671
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Category-specific visual identification of filtered objects in Alzheimer's disease.
    Viggiano MP; Gori G; Zaccara G; Righi S; Vannucci M; Giovannelli F
    Arch Gerontol Geriatr; 2007; 44(2):125-39. PubMed ID: 16762429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Task-dependent deficits during object release in Parkinson's disease.
    Gordon AM
    Exp Neurol; 1998 Oct; 153(2):287-98. PubMed ID: 9784288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
    Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
    Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of L-DOPA on spatiotemporal contrast sensitivity in Parkinson's disease.
    Mestre DR; Blin O; van den Brand CL; Azulay JP; Serratrice G
    Adv Neurol; 1996; 69():503-11. PubMed ID: 8615172
    [No Abstract]   [Full Text] [Related]  

  • 28. Levodopa improves time-based prospective memory in Parkinson's disease.
    Costa A; Peppe A; Brusa L; Caltagirone C; Gatto I; Carlesimo GA
    J Int Neuropsychol Soc; 2008 Jul; 14(4):601-10. PubMed ID: 18577289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential role of dopamine in emotional attention and memory: evidence from Parkinson's disease.
    Hälbig TD; Assuras S; Creighton J; Borod JC; Tse W; Frisina PG; Voustianiouk A; Gracies JM; Olanow CW
    Mov Disord; 2011 Aug; 26(9):1677-83. PubMed ID: 21638322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative study of salivary secretion in Parkinson's disease.
    Tumilasci OR; Cersósimo MG; Belforte JE; Micheli FE; Benarroch EE; Pazo JH
    Mov Disord; 2006 May; 21(5):660-7. PubMed ID: 16419045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poor visual discrimination and visual hallucinations in Parkinson's disease.
    Diederich NJ; Goetz CG; Raman R; Pappert EJ; Leurgans S; Piery V
    Clin Neuropharmacol; 1998; 21(5):289-95. PubMed ID: 9789709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease.
    Yokochi M
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levodopa therapy reduces DNA damage in peripheral blood cells of patients with Parkinson's disease.
    Cornetta T; Palma S; Aprile I; Padua L; Tonali P; Testa A; Cozzi R
    Cell Biol Toxicol; 2009 Aug; 25(4):321-30. PubMed ID: 18523852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Category-specific visual recognition as affected by aging and expertise.
    Viggiano MP; Righi S; Galli G
    Arch Gerontol Geriatr; 2006; 42(3):329-38. PubMed ID: 16274759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salivary production in Parkinson's disease.
    Proulx M; de Courval FP; Wiseman MA; Panisset M
    Mov Disord; 2005 Feb; 20(2):204-7. PubMed ID: 15389996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
    Doan JB; Melvin KG; Whishaw IQ; Suchowersky O
    Behav Brain Res; 2008 Dec; 194(2):207-13. PubMed ID: 18692094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease.
    Ibarretxe-Bilbao N; Junque C; Tolosa E; Marti MJ; Valldeoriola F; Bargallo N; Zarei M
    Eur J Neurosci; 2009 Sep; 30(6):1162-71. PubMed ID: 19735293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feedback-based versus observational classification learning in healthy aging and Parkinson's disease.
    Schmitt-Eliassen J; Ferstl R; Wiesner C; Deuschl G; Witt K
    Brain Res; 2007 Apr; 1142():178-88. PubMed ID: 17300759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Category-specificity in visual object recognition.
    Gerlach C
    Cognition; 2009 Jun; 111(3):281-301. PubMed ID: 19324331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.